Posts

​Pneumonia Symptoms You Shouldn’t Ignore - AARP

Image
Brothers91 / Getty Images En español It's pretty typical to develop a cough or an upper respiratory infection in the winter. Most of the time you get over it quickly. But sometimes, a winter illness can develop into pneumonia, a lung infection that is particularly dangerous for older adults. In a typical year, about 1.5 million Americ...

Elderly Pneumonia: Symptoms, Causes, Treatment & Prevention - Healthline

Image
Pneumonia is an infection where the tiny air sacs in your lungs (alveoli) become inflamed. This can lead to symptoms such as cough and shortness of breath. Pneumonia can be serious for some groups, one of which is older adults. In fact, a recent study estimated that almost 1 million adults ages 65 years or over are hospitalized with pneumonia each year in the United States. There are a couple reasons why pneumonia can be more severe in older adults: Keep reading as we discuss pneumonia in older adults, diving deeper into its symptoms, causes, and treatment. The symptoms of pneumonia in older individuals can differ from those in other age groups. Older adults with pneumonia may be more likely to: feel weak or unsteady, which can increase the risk of falling be without a fever or have a body temperature that's lower than normal experience confusion or delirium have changes in functional status, which is the ability to perform daily activities experience urinary incontinence lack an ...

Kids with asthma should get COVID vaccine, other questions answered - Hamilton Journal News

...

How to Tell If You Have Asthma - Healthline

Image
Asthma is a respiratory condition caused by inflammation and constriction (narrowing) of the airways. It's a long-term (chronic) condition that requires lifelong management and treatment to help prevent symptoms and reduce your chances of having an asthma attack. But how do you know for sure if you have asthma? If you're experiencing a cough or shortness of breath, learn what differentiates asthma from other respiratory conditions and how a doctor can confirm a diagnosis, so you can get the right treatment for your symptoms. Wheezing, coughing, and shortness of breath are among the most common asthma symptoms. In severe flare-ups, you may also feel tightness in your chest. Unlike other respiratory conditions, asthma symptoms tend to flare up when you're exposed to triggers, such as: allergens that irritate the airways and cause inflammation exercise that can put stress on the airways and lead to inflammation cold weather conditions that constrict the airways Symptoms also t...

Rheumatoid arthritis and gastrointestinal symptoms: Causes and more - Medical News Today

Image
Rheumatoid arthritis (RA) is an autoimmune condition that mainly affects a person's joints. However, RA can also cause symptoms that affect the gastrointestinal (GI) system, such as nausea, indigestion, and abdominal pain. The GI system contains many different organs, including the: This article discusses the effect of RA on the GI system, and the resulting symptoms. It also provides information on the relationship between GI problems and RA medication, as well as treatment options and prevention methods. There are many important connections between the GI system and RA. Some scientists believe RA could occur due to complex interactions between the gut microbiome, genetics, and environmental factors. RA is an autoimmune disease. This means that it develops when a person's immune system, whose role is to protect the body against disease, attacks healthy cells instead. The primary symptom of RA is inflammation of the joints. However, RA can affect almost every organ in the body...

Year in Review: Psoriatic Arthritis | MedPage Today - MedPage Today

Image
The year 2021 saw additional advances and refinements in the treatment of psoriatic arthritis (PsA), a heterogeneous condition that in the past has lagged behind rheumatoid arthritis (RA) in therapeutic progress. But improved understanding of the pathogenesis of PsA has allowed more targeted, safer, and more effective treatment approaches. In particular, data have begun to emerge from head-to-head and comparative studies of the newer agents and for difficult-to-treat disease manifestations, with the goal of helping clinicians choose among the increasing available options. Guselkumab (Tremfya) In a presentation at the 2021 European League Against Rheumatism (EULAR) virtual congress, guselkumab showed high rates of efficacy among PsA patients who had previously been treated unsuccessfully with tumor necrosis factor (TNF) inhibitors. Guselkumab is a monoclonal antibody that targets the p19 subunit of interleukin (IL)-23, and was shown in two pivotal phase III trials to be effective ...